Tranquis Therapeutics - Products ^Investors

Clinical-stage biopharmaceutical companyВідповідно до джерел: 2Tranquis Therapeutics, a pioneering clinical-stage biopharmaceutical company based in California, is at the forefront of developing innovative small molecule drugs that can reprogram dysfunctional myeloid immune cells to restore normal cell Therapeutics is a clinical-stage biopharmaceutical company developing a portfolio of small molecule therapeutics based on its unique approach of reprogramming dysfunctional myeloid immune cells to restore normal cell homeostasis and releases -